CN Patent

CN106831789A — 布鲁顿酪氨酸激酶抑制剂

Assigned to Nanjing Gentai Medical Technology Co Ltd · Expires 2017-06-13 · 9y expired

What this patent protects

本发明涉及式I的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、异构体或前药，包含式I的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的抑制剂用于制备预防或治疗异种免疫性疾病、自身免疫性疾病或癌症的药物的用途。

USPTO Abstract

本发明涉及式I的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、异构体或前药，包含式I的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的抑制剂用于制备预防或治疗异种免疫性疾病、自身免疫性疾病或癌症的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN106831789A
Jurisdiction: CN
Classification: —
Expires: 2017-06-13
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Gentai Medical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.